Pfizer Meningococcal Vaccine Nabs FDA Nod, Offering More Convenient Dosing
The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses all of them in a single vaccine, making dosing easier for patients.